Estimaciones de analistas de Wall Street para Eupraxia Pharmaceuticals Inc. (EPRX): precio objetivo de consenso, recomendaciones de compra/mantener/venta y previsiones de ingresos, BPA y EBITDA para los próximos ejercicios.
Sorpresas de Resultados Recientes
| Fecha | BPA Real | BPA Estimado | vs Est. |
|---|---|---|---|
| 2026-11-03 | $-0.27 | ||
| 2026-08-11 | $-0.16 | $-0.23 | +30.6% |
| 2026-05-12 | $-0.23 | $-0.22 | -4.5% |
| 2026-03-12 | $-0.37 | $-0.16 | -131.2% |
| 2025-11-04 | $-0.19 | $-0.23 | +17.4% |
| 2025-08-12 | $-0.26 | $-0.21 | -23.8% |
| 2025-05-06 | $-0.21 | $-0.19 | -10.5% |
| 2025-03-20 | $-0.21 | $-0.18 | -16.7% |
Ratios de valoración
| Precio / Valor contable | 4.72 |
| EV / EBITDA | -3.94 |
| Rentabilidad por dividendo | 0.00% |
Cuenta de Resultados (10 años)
| Año | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Ingresos | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Coste de Ventas | $86623 | $125426 | $207440 | $117072 | 0 | 0 | 0 | 0 | 0 |
| Beneficio Bruto | -$86623 | -$125426 | -$207440 | -$117072 | 0 | 0 | 0 | 0 | 0 |
| I+D | $3.4M | $6.8M | $3.5M | $1.1M | $10.2M | $13.6M | $15.3M | $16.1M | $21.3M |
| Generales y Administrativos | $1.5M | $5.1M | $3.1M | $1.3M | $8.2M | $4.0M | $5.6M | $10.9M | $17.1M |
| Gastos Operativos | $4.8M | $11.9M | $6.6M | $2.4M | $18.4M | $17.6M | $21.0M | $27.0M | $38.4M |
| Beneficio Operativo | -$4.9M | -$12.0M | -$6.8M | -$2.5M | -$18.4M | -$17.6M | -$21.0M | -$27.0M | -$38.4M |
| EBITDA | -$4.9M | -$14.5M | -$5.7M | -$2.0M | -$17.9M | -$17.9M | -$20.8M | -$25.0M | -$38.3M |
| Gastos por Intereses | $52806 | $142173 | $1.5M | $1.9M | $1.2M | $982856 | $881053 | $603573 | 0 |
| Beneficio Antes de Impuestos | -$5.1M | -$14.8M | -$7.4M | -$4.0M | -$24.3M | -$19.0M | -$21.8M | -$25.7M | -$38.6M |
| Impuestos | 0 | 0 | 0 | 0 | 0 | 0 | $27423 | $1804 | $19091 |
| Beneficio Neto | -$4.4M | -$13.2M | -$7.4M | -$4.0M | -$24.0M | -$18.5M | -$21.2M | -$25.5M | -$38.6M |
| BPA | $-0.34 | $-1.03 | $-0.56 | $-0.31 | $-1.93 | $-0.96 | $-0.88 | $-0.76 | $-1.03 |
| BPA Diluido | $-0.34 | $-1.03 | $-0.56 | $-0.31 | $-1.93 | $-0.96 | $-0.88 | $-0.76 | $-1.03 |
| Acciones en Circulación (Diluidas) | $12.9M | $12.9M | $12.9M | $12.9M | $12.4M | $19.3M | $24.1M | $33.9M | $40.0M |
Precio
| Precio | $8.09 |
| Capitalización | $271M |
| Bolsa | NASDAQ |
| País | CA |
Empresas relacionadas: AARD · GNFT · IVA · MDWD · NAUT · NTHI · OBIO
Explorar sector: Healthcare · Biotechnology
Más secciones de EPRX: Resumen · Financieros · Valoración · Estadísticas · Técnico · Propiedad · Noticias · Eventos
Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones